
Aglodom 1mg/ml Drop
Marketer
Aglowmed Drugs Pvt. Ltd.
Salt Composition
Domperidone (1mg/ml)
Overview Aglodom 1mg/ml Drop
PediaGast 1mg/ml oral drops effectively manage indigestion, gastroesophageal reflux, nausea, and vomiting in pediatric patients. It accelerates gastric emptying and intestinal transit, alleviating symptoms like bloating, satiety, and stomach upset. Administer PediaGast 30 minutes prior to meals for optimal absorption; post-meal administration remains effective but may reduce bioavailability. Infants may require four daily doses, as directed by their physician, spaced at least four hours apart, ideally before each feeding. Dosage is individualized based on age, weight, and clinical presentation. Never extend treatment beyond the prescribed duration without consulting a doctor. If vomiting occurs within 30 minutes, repeat the dose once the child is calm; however, avoid doubling the dose if nearing the next scheduled administration. Minor, transient side effects, including dry mouth, headache, somnolence, abdominal cramps, and diarrhea, may occur, usually resolving with continued use. Persistent or concerning side effects necessitate immediate medical attention. Prior to treatment, inform your child's physician of any history of allergies, cardiac conditions, hematological disorders, congenital anomalies, airway obstruction, pulmonary abnormalities, gastrointestinal issues, dermatological problems, hepatic impairment, or renal dysfunction. A comprehensive medical history enables the physician to optimize dosage and treatment strategy.
Primary Ingredients of Aglodom 1mg/ml Drop
No information provided. Please provide the text you wish to be rewritten.
Uses of Aglodom 1mg/ml Drop
Managing gastroesophageal reflux disease (GERD) | Addressing indigestion | Relieving nausea | Treating vomiting
Major Benefits of Aglodom 1mg/ml Drop:
Administer this medication precisely as your physician prescribes, adhering to both the dosage and treatment duration. Always consult the product label for usage instructions prior to consumption. Use a calibrated dropper for accurate measurement and ingestion. Aglodom 1mg/ml drops should be ingested on an empty stomach.
Common Side effects of Aglodom 1mg/ml Drop:
- Dryness in mouth
- Headache
- Drowsiness
- Stomach cramp
- Diarrhea
How to use Aglodom 1mg/ml Drop:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Always consult the product label for usage instructions prior to consumption. Employ the provided calibrated dropper for accurate measurement and ingestion. Aglodom 1mg/ml drops should be consumed on an empty stomach.
How Aglodom 1mg/ml Drop works:
Aglodom 1mg/ml drops stimulate gastrointestinal motility. This prokinetic agent targets the brain's vomiting center, while simultaneously enhancing gastric and intestinal transit in the upper digestive tract, facilitating smoother food passage.
SAFETY ADVICE
KidneyCAUTION
Patients with severe kidney impairment should use Aglodom 1mg/ml drops cautiously. Dosage modification of Aglodom 1mg/ml drops might be necessary. Physician consultation is advised. Regular assessment of kidney function, especially during prolonged treatment, may be important.
LiverCAUTION
Patients with liver impairment should use Aglodom 1mg/ml drops cautiously, potentially requiring dosage modification. Medical advice is essential. Aglodom 1mg/ml drops are unsuitable for children with severe hepatic dysfunction; pediatric consultation is necessary prior to administration.
What if you forget to take Aglodom 1mg/ml Drop :
If your pediatrician hasn't directed otherwise, administer the missed dose upon recollection. However, omit the missed dose if the next scheduled dose is imminent. Avoid doubling the dose to compensate; instead, adhere to the recommended dosing instructions.
Facts to Know About Aglodom 1mg/ml Drop
| Label | Value |
|---|---|
| Chemical Category | Benzimidazole-based compound |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Actions | Prokinetic agent with dopamine (D2) receptor antagonism |
